Literature DB >> 25174582

Angiopoietin-like protein 2 negatively regulated by microRNA-25 contributes to the malignant progression of colorectal cancer.

Jumei Zhou1, Jing Wang1, Shengqi Wu1, Suyu Zhu1, Sai Wang1, Huijun Zhou1, Xiaoqing Tian1, Ning Tang1, Shaolin Nie1.   

Abstract

Angiopoietin-like protein 2 (ANGPTL2) is associated with tumor progression while dysregulation of its expression has been observed in various types of cancer. However, the expression and role of ANGPTL2 remain exclusive in colorectal cancer (CRC). In the present study, we determined the expression levels of ANGPTL2 in CRC tissues and cells. The roles of ANGPTL2 and miR-25 in the migration and invasion of CRC SW620 and HCT-116 cells were also investigated using transwell assays or scratch wound assays. The results showed that ANGPTL2 increased with metastatic progression. Increased ANGPTL2 and decreased microRNA-25 (miR-25) expression were found to coexist in CRC. The functional studies revealed that knockdown of ANGPTL2 reduced colony formation, and the invasive and migratory abilities of human CRC SW620 and HCT-116 cells. Similarly, overexpression of miR-25 resulted in reduced colony formation, invasion and migration in both cell lines. The overexpression of miR-25 led to a decreased ANGPTL2 mRNA and protein expression, whereas the downregulation of miR-25 resulted in increased ANGPTL2 mRNA and protein expression, in SW620 and HCT-116 cells. miR-25 directly targeted ANGPTL2 by binding to its 3'‑UTR, as determined by the dual luciferase reporter assay. To the best of our know-ledge, the results of this study suggest for the first time that the abnormal upregulation of ANGPTL2 in CRC is associated with miR-25 downregulation. Additionally, miR-25‑mediated ANGPTL2 promoted the malignant progression of CRC. The present study provides evidence supporting ANGPTL2 and miR-25 as diagnostic or therapeutic targets for CRC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25174582     DOI: 10.3892/ijmm.2014.1909

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  7 in total

1.  Prognostic role of microRNA-25 in cancers: evidence from a meta-analysis.

Authors:  Jingjing Qu; Min Li; Wen Zhong; Chengping Hu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Upregulated MicroRNA-25 Mediates the Migration of Melanoma Cells by Targeting DKK3 through the WNT/β-Catenin Pathway.

Authors:  Jia Huo; Yanfei Zhang; Ruilian Li; Yuan Wang; Jiawen Wu; Dingwei Zhang
Journal:  Int J Mol Sci       Date:  2016-10-27       Impact factor: 5.923

Review 3.  High Circulating Levels of ANGPTL2: Beyond a Clinical Marker of Systemic Inflammation.

Authors:  Nathalie Thorin-Trescases; Eric Thorin
Journal:  Oxid Med Cell Longev       Date:  2017-08-24       Impact factor: 6.543

4.  miR-25 enhances cell migration and invasion in non-small-cell lung cancer cells via ERK signaling pathway by inhibiting KLF4.

Authors:  Xiaoli Ding; Tianyu Zhong; Lixia Jiang; Junyun Huang; Yu Xia; Rong Hu
Journal:  Mol Med Rep       Date:  2018-03-16       Impact factor: 2.952

5.  Dihydroartemisinin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cell by Upregulating Tumor Necrosis Factor via JNK/NF-κB Pathways.

Authors:  Long Wu; Yanlei Cheng; Junjian Deng; Weiping Tao; Junjie Ye
Journal:  Evid Based Complement Alternat Med       Date:  2019-08-25       Impact factor: 2.629

6.  Evaluation of circulating microRNAs-211 and 25 as diagnostic biomarkers of colorectal cancer.

Authors:  Eman Radwan; Asmaa S Shaltout; Shima Gafar Mansor; Engy A Shafik; Wael A Abbas; Mahmoud Refaat Shehata; Maha Ali
Journal:  Mol Biol Rep       Date:  2021-06-16       Impact factor: 2.316

7.  Correlation of clinical features and genetic profiles of stromal interaction molecule 1 (STIM1) in colorectal cancers.

Authors:  Henry Sung-Ching Wong; Wei-Chiao Chang
Journal:  Oncotarget       Date:  2015-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.